Mechanisms of Anti-Tumor Activity of STAT3 Degraders in Lymphoma

December 7, 2020

62nd American Society of Hematology (ASH) Virtual Annual Meeting and Exposition

Mechanisms of Anti-Tumor Activity of STAT3 Degraders in Lymphoma_IMAGE
Area of Focus
Oncology
Programs
STAT3 (KT-333)
Indications
Liquid Tumors
Development Stage
Pre-clinical Data
Share
LinkedInXFacebookEmailCopy Link